Retraction notice: “MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway”

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: SAGE Publishing 2025-03-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.1177/11795549251328453
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849344261031460864
collection DOAJ
format Article
id doaj-art-7e34cf0615d74d68a67cc1e446922a35
institution Kabale University
issn 1179-5549
language English
publishDate 2025-03-01
publisher SAGE Publishing
record_format Article
series Clinical Medicine Insights: Oncology
spelling doaj-art-7e34cf0615d74d68a67cc1e446922a352025-08-20T03:42:43ZengSAGE PublishingClinical Medicine Insights: Oncology1179-55492025-03-011910.1177/11795549251328453Retraction notice: “MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway”https://doi.org/10.1177/11795549251328453
spellingShingle Retraction notice: “MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway”
Clinical Medicine Insights: Oncology
title Retraction notice: “MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway”
title_full Retraction notice: “MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway”
title_fullStr Retraction notice: “MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway”
title_full_unstemmed Retraction notice: “MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway”
title_short Retraction notice: “MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway”
title_sort retraction notice microrna 19b downregulates nr3c1 and enhances oxaliplatin chemoresistance in colon cancer via the pi3k akt mtor pathway
url https://doi.org/10.1177/11795549251328453